This review assesses markers of endothelial dysfunction (ED) associated with the maternal
syndrome of preeclampsia (PE). We evaluate the role of antiretroviral therapy (ART) in …

Background Antiretroviral therapy (ART) alters platelet reactivity, and as a consequence,
patients living with HIV may be at an increased risk of cardiovascular disease (CVD). The …

Introduction Human immunodeficiency virus (HIV) infection can be considered a chronic
disease thanks to the extended use of antiretroviral treatment (ART). In this context, low …

People living with HIV (PLWHIV) present an increased risk of adverse cardiovascular
events. We aimed to assess whether antiretroviral therapy (ART) pharmacologically …

Introduction Recent evidence has raised questions about whether newer HIV treatment
regimens, including dolutegravir (DTG) and tenofovir alafenamide (TAF), are associated with …

Background After the introduction of antiretroviral therapy, the care given to people living
with HIV has become complicated by the appearance of comorbidities as a result of HIV and …

Objectives There is a growing need to understand the potential role of soluble platelet
selectin (sP-selectin) in sustained endothelial activation through increased levels of soluble …

Background Human Immunodeficiency Virus (HIV) and its therapy cause a variety of
hematological abnormalities that have been known to be one of the most common causes of …

HIV infection results in marked alterations in the gut microbiota (GM), such as the loss of
microbial diversity and different taxonomic and metabolic profiles. Despite antiretroviral …

One of the remarkable recent pivots in the entire HIV field is the shift from resistance and
early antiretroviral toxicity to the challenge facing the global population: growing old while …